Specialized statistical solution helps rare disease biotech analyze complex trial data, cutting validation time by 40% and boosting submission accuracy from 75% to 90%.
COMPANY OVERVIEW
Boston-based biotechnology company focused on rare disease therapeutics, managing a portfolio of 15+ complex clinical trials across 12 countries.